Healthcare Industry News: Healthpoint
News Release - June 12, 2007
Sherlene Bagley Named Director, Portfolio Development for HEALTHPOINT, Ltd.FORT WORTH, Texas, June 12 (HSMN NewsFeed) -- Robert E. Bancroft, General Manager of Healthpoint, Ltd., recently announced that Sherlene Bagley has been promoted to Director of Portfolio Development for Healthpoint, a part of DFB Branded Pharmaceuticals.
As Healthpoint's Director of Portfolio Development, Ms. Bagley is responsible for developing product life cycle and strategic business plans to optimize the commercial potential of new and existing pharmaceuticals, biologics and medical devices. In her role, she will work directly with JR Locey, Vice President of Strategic and Business Development and other business development leaders of Healthpoint and DFB Branded Pharmaceuticals.
"Sherlene has been an integral part of the Healthpoint marketing team since 2003," said Mr. Bancroft. "For four years, Sherlene's strong marketing and business skills have been a valuable asset to this company, and she will no doubt display the same during the next stages of our growth."
Ms. Bagley was most recently Strategic Product Director for the Portfolio Development group. There, she focused on the Healthpoint's Tissue Management division development portfolio, assessing and quantifying wound care market opportunities and bringing new products to the market. Prior to her role as Strategic Product Director, Ms. Bagley was Product Director for two flagship products, ACCUZYME® (papain, urea) Ointment/SE and PANAFIL® (papain, urea, chlorophyllin copper complex sodium) Ointment/SE.
Earlier in her career, Ms. Bagley was Senior Product Director in the Advanced Wound Care group of Johnson & Johnson Wound Management after more than 20 years in various operations and marketing roles in the kitchen and bath industry. A graduate of the University of Texas at Arlington, she also worked in the bath, hair and skincare products marketplace before coming to Healthpoint.
DFB Branded Pharmaceuticals is a recently established segment of DFB Pharmaceuticals, Inc. Under DFB Branded Pharmaceuticals, the formerly autonomous Healthpoint Tissue Management and Surgical divisions united to form one Healthpoint.
Since its inception in 1992, Healthpoint has established a U.S. presence in the research, development, and marketing of branded pharmaceuticals, over the counter drugs, and medical devices for tissue management and surgical indications. An aggressive research and development effort has brought Healthpoint's unique technologies to the market, setting the pace for its highly trained field sales organization of direct sales representatives. Healthpoint, with over 300 employees, is part of DFB Branded Pharmaceuticals, a DFB Pharmaceuticals, Inc. business segment. Healthpoint is based in Fort Worth, Texas. Visit Healthpoint on the web at http://www.Healthpoint.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.